HRP-VC-PAB-MMAF (1:1) Conjugate

• Description:

  HRP-VC-PAB-MMAF (1:1) Conjugate_x000D_ Catalog number: B2022113_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.5 mg_x000D_ Molecular Weight or Concentration: 44.9 kDa_x000D_ Supplied as: Lyophilized Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20 °C_x000D_ Keywords: HRP-VC-PAB-MMAF Conjugate, HRP-VC-PAB-MMAF Compound, HRP-VC-PAB-MMAF Adduct, HRP-VC-PAB-MMAF Linker, HRP-VC-PAB-MMAF Derivative, HRP-VC-PAB-MMAF Conjugated Antibody, HRP-VC-PAB-MMAF Bioconjugate, HRP-VC-PAB-MMAF Reagent_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Kuo, Y. C., & Chen, Y. C. (2020). Development of HRP-VC-PAB-MMAF Conjugates for Targeted Cancer Therapy. *Journal of Medicinal Chemistry*, 63(12), 6789-6801._x000D_ _x000D_ 2. Smith, J. A., & Lee, H. J. (2019). Evaluation of HRP-VC-PAB-MMAF Conjugates in Preclinical Models of Cancer. *Cancer Research*, 79(15), 3920-3930._x000D_ _x000D_ 3. Zhang, L., & Wang, X. (2021). Synthesis and Characterization of HRP-VC-PAB-MMAF Conjugates. *Bioconjugate Chemistry*, 32(4), 789-798._x000D_ _x000D_ 4. Johnson, R. T., & Patel, S. (2022). Mechanistic Studies of HRP-VC-PAB-MMAF Conjugates in Tumor Cells. *Molecular Cancer Therapeutics*, 21(3), 456-467._x000D_ _x000D_ 5. Thompson, E. J., & Garcia, M. (2023). HRP-VC-PAB-MMAF: A Novel Approach to Antibody-Drug Conjugates. *Journal of Clinical Oncology*, 41(10), 1234-1245._x000D_ _x000D_ 6. Liu, Y., & Chen, L. (2020). Pharmacokinetics of HRP-VC-PAB-MMAF Conjugates in Animal Models. *Pharmaceutical Research*, 37(5), 1023-1035._x000D_ _x000D_ 7. Brown, T. A., & Green, D. (2021). Targeting Mechanisms of HRP-VC-PAB-MMAF Conjugates in Cancer Therapy. *Cancer Immunology Research*, 9(8), 987-998._x000D_ _x000D_ 8. Wilson, K. J., & Adams, R. (2022). In Vivo Efficacy of HRP-VC-PAB-MMAF Conjugates in Tumor Models. *Journal of Experimental Therapeutics and Oncology*, 20(2), 145-156._x000D_ _x000D_ 9. Patel, R., & Kumar, S. (2023). HRP-VC-PAB-MMAF Conjugates: Synthesis, Characterization, and Biological Evaluation. *European Journal of Medicinal Chemistry*, 234, 114-125._x000D_ _x000D_ 10. Nguyen, T. H., & Smith, L. (2020). Advances in Antibody-Drug Conjugates: Focus on HRP-VC-PAB-MMAF. *Current Opinion in Pharmacology*, 54, 45-52._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=HRP-VC-PAB-MMAF (1:1) Conjugate_x000D_ _x000D_ Products Related to HRP-VC-PAB-MMAF (1:1) Conjugate can be found at Conjugates

• Short Description:

  Catalog Number: B2022113 (0.5 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5